CARDINAL HEALTH, INC. DUBLIN, OHIO - August 19, 2021 - On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9% Sodium Chloride). The products have been found to reintroduce air into the syringe after the air has been expelled. This could result in injection of air into blood vessels and create the potential for air embolism, which can cause serious adverse health outcomes or death.
Customers who have affected product(s) should immediately review their inventory and quarantine and return all affected product. The recall applies to all lots of the products manufactured from July 2019 to June 2021 distributed between July 2019 and July 2021.
The following SKUs have been recalled:
Name of Product | SKUs |
12mL Syringe, 10 mL Saline Fill | 8881570121 |
12mL Syringe, 3 mL Saline Fill | 8881570123 |
12mL Syringe, 5 mL Saline Fill | 8881570125 |
Our Monoject™ 3mL syringe, 2.5mL Saline Fill is not affected by this recall. This item, SKU 8881570300, will be available for sale until inventory is depleted.
MonojectTM Flush Prefilled Saline Syringes can be identified by the barrel of the syringe, the case and the box as shown in the pictures below:
| Barrel Print | Box Print | Case Print |
| [Link] | [Link] | [Link] |
The company has received 37 reports of the plunger pulling back. No injuries have been reported to date.Cardinal Health voluntarily recalled MonojectTM Flush Prefilled Saline Syringes after learning that there is potential for the syringe's plunger to draw back and reintroduce air back into the syringe. Cardinal Health has notified the U.S. Food and Drug Administration of this action.
Cardinal Health notified its distributors and customers by overnight delivery of a notification packet on August 5, 2021 and is arranging for return of all recalled products.
Cardinal Health distributes this product nationwide.
Customers with questions may contact the market action team via telephone at 800-292- 9332 between the hours of 8 a.m. - 5 p.m. EST. Customers may also contact the team via email at GMB-FieldCorrectiveAction@cardinalhealth.com.
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program online, by mail or by fax:
- Complete and submit the report online: www.fda.gov/medwatch/report.htm.
- Regular Mail or Fax: Download form (www.fda.gov/MedWatch/getforms.htm) or call 1-800-332-1088 to request a reporting form, then complete and either return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.
Given the limited number of alternative prefilled saline syringe options, combined with ongoing supply, transportation and labor challenges, we anticipate that this recall may contribute to a market disruption of prefilled saline syringes. We are actively working to address the disruption and support customers' needs with locating alternative supply and we suggest that clinicians work with their facility to determine alternative fill methods.
For more information and the latest updates, please visit cardinalhealth.com/MonojectFlushPrefilledSalineSyringesIssue.
About Cardinal Health
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. Information about Cardinal Health is available at cardinalhealth.com.
Contacts
Media: Andrew Stern, andrew.stern@cardinalhealth.com and (614) 339-4678
DUBLIN, OHIO - August 19, 2021 - On August 4, 2021, Cardinal Health (NYSE: CAH) initiated a nationwide recall of approximately 267 million MonojectTM Flush Prefilled Saline Syringes (0.9%...
Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as...
Cardinal Health is pleased to announce an agreement with TerraPower that will help advance the next generation of cancer treatment. Working together, the companies will develop and produce...
Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027....
View all company news »
Attachments
- Original document
- Permalink
Disclaimer
Cardinal Health Inc. published this content on 19 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 August 2021 21:43:03 UTC.
